Kashyap, M. K., Kumar, D., Jones, H., Amaya-Chanaga, C. I., Choi, M. Y., Melo-Cardenas, J., . . . Castro, J. E. (2015). Ulocuplumab (BMS-936564 / MDX1338): A fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway. Oncotarget.
Citação norma ChicagoKashyap, Manoj K., et al. "Ulocuplumab (BMS-936564 / MDX1338): A Fully Human Anti-CXCR4 Antibody Induces Cell Death in Chronic Lymphocytic Leukemia Mediated Through a Reactive Oxygen Species-dependent Pathway." Oncotarget 2015.
Citação norma MLAKashyap, Manoj K., et al. "Ulocuplumab (BMS-936564 / MDX1338): A Fully Human Anti-CXCR4 Antibody Induces Cell Death in Chronic Lymphocytic Leukemia Mediated Through a Reactive Oxygen Species-dependent Pathway." Oncotarget 2015.